EleftheriosMylonakisMD

Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Dr. Mylonakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6550 Fannin St
Ste 1001
Houston, TX 77030
Phone+1 617-670-9115

Fax+1 713-790-2797

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1999 - 2003
Brown UniversityResidency, Internal Medicine, 1995 - 1999
University of AthensClass of 1990

PubMed

Treatment of Macrolide-resistant Mycoplasma pneumoniae Pneumonia in Children: A Meta-analysis of Macrolides Versus Tetracyclines.
Erdenetuya Bolormaa, Ji Young Park, Young June Choe, Cho Ryok Kang, Seung Ah Choe
The Pediatric Infectious Disease Journal. 2025-03-01
Mefloquine reduces the bacterial membrane fluidity ofand distorts the bacterial membrane when combined with polymyxin B.
Nagendran Tharmalingam, Harikrishna Sekar Jayanthan, Jenna Port, Fernanda Cristina Possamai Rossatto, Eleftherios Mylonakis
Mbio. 2025-02-25
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
Ahmad Mourad, Gregory A Grandits, Lianne K Siegel, Nicole Engen, Christina Barkauskas
Clinical Microbiology and Infection. 2025-02-06

Journal Articles

The Cost-Effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections
Elina Eleftheria Pliakos, Nikolaos Andreatos, Eleftherios Mylonakis, Clinical Infectious Diseases
The Global Alliance for Infections in Surgery: Defining a Model for Antimicrobial Stewardship—Results from an International Cross-Sectional Survey
Richard R Watkins, Eleftherios Mylonakis, Robert G Sawyer, Costi D Sifri, BioMed Central

Rice and Houston Methodist Award Seed Grants for Digital Health ResearchJanuary 2nd, 2025
FDA Committee OKs Modifying Boosters; Challenges Ahead for ManufacturersJune 29th, 2022
Coronavirus Chronicles — Hitting Kids HardDecember 30th, 2021
Join now to see all